Customize your JAMA Network experience by selecting one or more topics from the list below.
In the Original Investigation titled “Treatment for Preventing Tuberculosis in Children and Adolescents: A Randomized Clinical Trial of a 3-Month, 12-Dose Regimen of a Combination of Rifapentine and Isoniazid” published online January 12, 2015, and in the March 2015 print issue of JAMA Pediatrics,1 a printing error occurred in Table 2. For the Treatment completion row, the difference (95% CI), which read “−7.2 (−2.0 to −2.5),” should be replaced with “−7.2 (−12.0 to −2.5).” This article was corrected online.
Erratum in Table. JAMA Pediatr. 2015;169(9):878. doi:10.1001/jamapediatrics.2015.2429
Create a personal account or sign in to: